FDA Inspection 1014959 — Adare Pharmaceuticals, Inc.
The FDA completed an inspection of Adare Pharmaceuticals, Inc. on May 19, 2017 in Vandalia, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 19, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Vandalia, OH (United States)